Form 4 for OMDA Omada Health, Inc.
Accepted 2026-08-11 16:17:55 ET · period of report 2026-08-07 · accession 0001610717-26-000354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-11 16:17 | 2026-08-07+ | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $8.95 | +21.6K | 424.8K | +5% | +$193.0K |
| DMT | 2026-08-11 16:17 | 2026-08-07+ | OMDA | Duffy Sean P. | CEO, Dir | S - Sale+OE | $23.62 | -21.6K | 411.9K | -5% | -$509.6K |
| DMT | 2026-08-11 16:17 | 2026-08-07+ | OMDA | Duffy Sean P. | CEO, Dir | M - OptEx | $0.00 | -21.6K | 517.3K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-07 | M | A | 5,545 | $8.28 | 417,406 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 2 | Common | Common Stock | 2026-08-07 | M | A | 3,083 | $9.18 | 420,489 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 3 | Common | Common Stock | 2026-08-07 | S | D | 4,314 | $20.90 | 416,175 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 4 | Common | Common Stock | 2026-08-07 | S | D | 4,314 | $22.80 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 5 | Common | Common Stock | 2026-08-10 | M | A | 12,942 | $9.18 | 424,803 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. |
| 6 | Common | Common Stock | 2026-08-10 | S | D | 12,942 | $24.81 | 411,861 | D | — | — | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F2) This transaction was executed in multiple trades at prices ranging from $24.70 to $25.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-07 | M | D | 5,545 | $0.00 | 110,532 | D | $8.28 · — to 2031-05-05 | 5,545 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-08-07 | M | D | 3,083 | $0.00 | 530,250 | D | $9.18 · — to 2032-02-10 | 3,083 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F4) 100% of the shares subject to the option are fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-08-10 | M | D | 12,942 | $0.00 | 517,308 | D | $9.18 · — to 2032-02-10 | 12,942 Common Stock | (F1) Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. (F4) 100% of the shares subject to the option are fully vested and exercisable. |